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Background
It is unclear whether people with post-traumatic stress disorder
(PTSD) and symptoms of complex PTSD due to childhood abuse
need a treatment approach different from approaches in the
PTSD treatment guidelines.
Aims
To determinewhether a phase-based approach ismore effective
than an immediate trauma-focused approach in people with
childhood-trauma related PTSD (Netherlands Trial Registry no.:
NTR5991).
Method
Adults with PTSD following childhood abuse were randomly
assigned to either a phase-based treatment condition (8 ses-
sions of Skills Training in Affect and Interpersonal Regulation
(STAIR), followed by 16 sessions of eye-movement desensitisa-
tion and reprocessing (EMDR) therapy; n = 57) or an immediately
trauma-focused treatment condition (16 sessions of EMDR
therapy; n = 64). Participants were assessed for symptoms of
PTSD and complex PTSD, and other forms of psychopathology
before, during and after treatment and at 3- and 6-month
follow-ups.
Results
Data were analysed with linear mixed models. No significant
differences between the two treatments on any variable at post-
treatment or follow-up were found. Post-treatment, 68.8% no
longer met PTSD diagnostic criteria. Self-reported PTSD
symptoms significantly decreased for both STAIR–EMDR therapy
(d = 0.93) and EMDR therapy (d = 1.54) from pre- to post-
treatment assessment, without significant difference between
the two conditions. No differences in drop-out rates between the
conditions were found (STAIR–EMDR 22.8% v. EMDR 17.2%). No
study-related adverse events occurred.
Conclusions
This study provides compelling support for the use of EMDR
therapy alone for the treatment of PTSD due to childhood abuse
as opposed to needing any preparatory intervention.
Keywords
Post-traumatic stress disorder; individual psychotherapy; cog-
nitive–behavioural therapies; childhood experience; dissociative
disorders.
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Repeated trauma in childhood has been found to be a risk factor for
developing complex post-traumatic stress disorder (complex
PTSD).1 Complex PTSD was officially introduced in ICD-11 as
part the ‘Disorders specifically associated with stress’ category.2
To fulfil the diagnostic criteria a person needs to display, in addition
to PTSD criteria, disturbances in three domains of self-organisation
(i.e. affect dysregulation, negative core beliefs and interpersonal pro-
blems). Eye-movement desensitisation and reprocessing (EMDR)
therapy and prolonged exposure therapies are effective trauma-
focused treatments for PTSD,1 but it is still unclear whether
people who meet criteria for complex PTSD need a different treat-
ment approach than those based on existing international treatment
guidelines for PTSD.3
Phase-based treatment approach
One of the treatment approaches for complex PTSD suggested, even
before complex PTSD was included in the ICD-11, is a phase-based
treatment.4 In the first phase – cognitive–behavioural therapy –
patients experiment with emotion regulation and interpersonal
skills. The second phase is trauma-focused treatment in which the
traumatic memories are processed. The third and final phase
focuses on the consolidation of treatment gains and the resumption
of daily activities.4 The purpose of the first phase is also to establish a
therapeutic relationship and increase safety and flexibility in skills.5
Evidence for the phase-based approach
The value of using a phase-based approach was supported by the
results of a three-armed randomised controlled clinical trial con-
ducted by Cloitre et al.6 This study evaluated the effectiveness of a
phased-based treatment approach by comparing three treatment
conditions: (a) eight sessions of Skills Training in Affect and
Interpersonal Regulation (STAIR),5 followed by eight sessions of
prolonged exposure therapy; (b) supportive counselling followed
by a comparable number of sessions of exposure therapy; and (c)
STAIR followed by supportive counselling (n = 104). Because the
outcomes of both conditions differed at follow-up for some vari-
ables (PTSD symptoms, interpersonal problems and several scales
for affect regulation) in favour of the STAIR/exposure condition,
the researchers concluded that the results of their study suggested
that a phase-based approach is superior to a trauma-focused
approach. However, the fact that a pure exposure condition was
lacking makes it difficult to draw conclusions about the relative ben-
efits of a phased-treatment approach over conventional trauma-
focused PTSD treatment.3
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Comparison of the phased-based approach with the
trauma-focused treatment
The most recent version of the treatment guidelines for complex
PTSD published by the International Society of Traumatic Stress
Studies (ISTSS) proposes a ‘personalised medicine’ approach
aimed at identifying symptoms that are clinically significant to a
particular patient and tailoring interventions to address these.1
The guideline committee acknowledged that research supporting
this guideline is lacking and that only a head-to-head comparison
of a phase-based treatment with an immediately trauma-focused
treatment using a randomised controlled design can answer this
important question. Recently, Oprel and her colleagues conducted
a randomised controlled trial (RCT) in which prolonged exposure
therapy was directly compared with a phase-based treatment (pro-
longed exposure therapy preceded by STAIR) among 149 indivi-
duals with PTSD due to childhood abuse.7 The hypothesis that
the phase-based treatment would be associated with larger PTSD
symptom reductions compared with the immediate prolonged
exposure therapy was not supported by their data. A comparable
study with EMDR therapy as the trauma-focused treatment has
not been performed.
Aim of the present study
The purpose of the present study was to help find an answer to the
question as to whether a phase-based treatment approach is more
effective than an immediately trauma-focused treatment in amelior-
ating the treatment outcomes in individuals with PTSD due to
repeated sexual and/or physical childhood abuse. To make a
direct comparison between both treatment options, two types of
therapy were applied: EMDR therapy preceded by STAIR,5 and
immediate EMDR therapy not preceded by STAIR. Because
STAIR was developed especially for individuals with PTSD and
symptoms of complex PTSD to ameliorate treatment outcomes,
we hypothesised that, compared with the EMDR therapy only con-
dition, the phase-based treatment condition would be significantly
more effective in reducing symptoms of PTSD, symptoms of
complex PTSD and other forms of psychopathology, and would




The study is a single-blind RCT with two arms (EMDR therapy
versus EMDR therapy preceded by STAIR) with measurements at
pre-treatment, every eight sessions, post-treatment and at 3- and
6-month follow-up. The design paper for this trial8 is available at
https://doi.org/10.1186/s13063-018-2508-8. This also includes a
CONSORT checklist. The study design was registered in the
Netherlands Trial Registry (NTR5991) and approved by the
medical ethics committee of the University of Twente, The
Netherlands (56641.044.16 CCMO).
Participants
Participants were recruited from two out-patient mental health
organisations in The Netherlands (Dimence and GGZ Oost-
Brabant) from 5 September 2016, and the last follow-up assessment
was on 28 August 2020. Patients were included if aged between 18
and 65 years and diagnosed with PTSD as measured by the
Clinician-Administered PTSD scale for DSM-5 (CAPS-5).9
Furthermore, they had to be a victim of repeated sexual and/or
physical abuse before the age of 18 by a caretaker or a person in a
position of authority, as identified by the LEC-5.10
Exclusion criteria
Patients were excluded if they displayed insufficient Dutch language
proficiency or an acute risk of suicidality for which immediate crisis
intervention was needed, as assessed by item 9 of the Beck
Depression Inventory - II (BDI-II).11 Also, they were excluded if
they had received treatment for PTSD in the past year with at
least eight sessions (any well-evaluated programme), reported
being a victim of ongoing physical and/or sexual abuse, reported
alcohol or drug dependence or misuse according to DSM-5 cri-
teria12 during screening for eligibility or if they had an intellectual
disability at registration at the institution.
Procedure
Individuals eligible for inclusion received oral and written informa-
tion about the study. If they agreed to participate and signed the
informed consent form, they were assessed for inclusion (n =
151). After inclusion, participants were randomly assigned to one
of the two treatment conditions (the exact randomisation procedure
is described in the design paper8).
Measurements
The self-reported severity of PTSD symptoms was the primary
outcome and was assessed by the PTSD Symptom Scale – Self-
Report version (PSS-SR)13 at pre-treatment, after eight sessions
and at post-treatment. The internal reliability at baseline was high
(Cronbach’s α = 0.83).
Several secondary outcome measures were included. The pres-
ence and severity of PTSD diagnoses were assessed using the
CAPS-59 at pre-treatment, post-treatment and at both follow-ups.
The presence and severity of symptoms of complex PTSD were
measured using the Structured Interview for Disorders of Extreme
Stress (SIDES),14 more specifically the 38-item version developed
by Ford et al.15
We investigated distinct symptoms of complex PTSD pre-treat-
ment, after eight sessions and post-treatment as follows. In addition
to the PTSD symptoms as indexed by the CAPS,9 symptoms of
complex PTSD were measured based on the symptom clusters of
the ICD-11 complex PTSD classification,2 that is, by using the
Inventory of Interpersonal Problems (IIP)16 to measure interper-
sonal difficulties (Cronbach’s α = 0.85 at baseline of the current
study), the Difficulties in Emotion Regulation Scale (DERS)17 to
assess difficulties in emotion regulation (Cronbach’s α = 0.92 at
baseline of the current study) and the Posttraumatic Cognitions
Inventory (PTCI)18 to index trauma-related thoughts and beliefs
(Cronbach’s α = 0.96 at baseline of the current study).
Trait dissociation was measured using the Dissociative
Experiences Scale II (DES-II)19 (Cronbach’s α = 0.93 at baseline of
the current study) at pre-treatment, post-treatment and both
follow-ups.
The Brief Symptom Inventory20 (Cronbach’s α = 0.95 at base-
line of the current study) was used to index symptoms of general
psychopathology at every measurement point.
Treatment
In both treatment conditions, participants first received one 90 min
session, consisting of psychoeducation and determining a hierarchy
of relevant traumatic experiences. Both the STAIR and EMDR
therapy were thereafter delivered twice a week for 90 min and ses-
sions were video recorded. STAIR was conducted according to the
programme described by Cloitre and her colleagues.5 EMDR
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therapy was conducted according to the protocol by Shapiro using
the Dutch translation of the treatment protocol.21 After treatment (8
sessions of STAIR followed by 16 sessions of EMDR therapy, or 16
sessions of EMDR therapy only), participants were not allowed to
receive psychological therapy for 6 months. Psychiatric consultation
or support by a nurse were allowed to prevent deterioration during
treatment and follow-up, but this had to be reported. Participants
were considered to have dropped out of the study if they left any
time after the first session. Patients were considered as early comple-
ters if all their trauma targets were processed and they did not meet
the criteria for PTSD anymore before the maximum amount of
treatment sessions. Those who dropped out as well as early comple-
ters were assessed at the planned time points. Regular monitoring of
participant safety was conducted by therapists and researchers, and
serious adverse events were recorded and reported to the main
researcher, who reported these to the medical ethics committee.
Therapists
All 27 participating therapists were experienced psychologists and
already trained (at advanced level) in EMDR therapy prior to the
trial. In addition, they received 2 days of training in STAIR from
an experienced STAIR protocol trainer (M.-L.M.) and a half-day
training on how to make a hierarchy of relevant traumatic experi-
ences with the patient from another of the authors (A.d.J.).
Within each condition, the participants were assigned to a therapist
based on availability.
Supervision and treatment fidelity
Supervisions took place every 2 months for both EMDR therapy
(provided by an EMDR Europe accredited trainer, A.d.J.) and
STAIR (provided by an experienced STAIR protocol trainer,
M.-L.M). All therapists received individual feedback about the
first set of video-recorded sessions at the start of a treatment. For
the rating of treatment fidelity, 15% of the sessions were randomly
selected and rated by the researchers for treatment adherence. A
perfectly executed STAIR protocol was rated as 100% (the percent-
age of well-performed interventions per session), and the mean per-
centage over the rated sessions was 98.01% (s.d. = 6.04). For EMDR
therapy sessions the maximum number of rated points was 15 (one
point for every observed step of the protocol), and the mean number
over the rated sessions was 14.45 (s.d. = 0.69). For each treatment
condition, six recorded sessions were rated by a second independent
rater, in order to compute the level of agreement between the
researchers and the rater. The agreement between the researcher
and the independent rater was 92.5% in the STAIR–EMDR condi-
tion and 96.7% in the EMDR condition and inconsistencies were
discussed.
Statistical analysis
Analyses were conducted using SPSS 27 for Windows.22 Possible
demographic baseline differences were analysed using χ2-tests.
Analyses were performed on an intention-to-treat basis. For dichot-
omous outcomes, a χ2-test was used to test differences in outcome
between the treatment conditions. For continuous variables, we
used a linear mixed models (LMM) analysis, with treatment condi-
tions and time (i.e. measurements at different time points) as cat-
egorical variables, using a covariance pattern model.23 Compound
symmetry was used as the covariance type and the standard
restricted maximum likelihood (REML) as the estimation method.
The STAIR–EMDR condition was the reference category. The ana-
lyses were conducted both with and without pre-measurement of
the respective outcome variable as a covariate. As the mixed linear
model analyses (LMM) without a covariate provides a better
overview for complete changes over time, these are represented in
the main text. The results for the LMM analyses with the pre-treat-
ment as a covariate are presented Supplementary Tables 3a and 3b,
available at https://doi.org/10.1192/bjo.2021.1057). To determine
whether participants experienced symptom improvement beyond
what could be attributed to measurement error, the reliable
change index (RCI) for the CAPS was calculated24 in combination
with test–retest reliability information based on previous research.25
Ethics statement
The authors assert that all procedures contributing to this work
comply with the ethical standards of the relevant national and insti-
tutional committees on human experimentation and with the
Helsinki Declaration of 1975, as revised in 2008. All procedures
involving human participants were approved by the Institutional
Review Board of the University of Twente (merged with the
Institutional Review Board United), reference number P16–03.
Results
Patient flow and sample characteristics
Figure 1 shows the flowchart of participants through the trial. Ten
individuals in the STAIR–EMDR group and one in the EMDR
group discontinued the trial before the start of treatment. The psy-
chopathological and demographic characteristics of participants
and those who discontinued did not differ at baseline, except for a
significantly lower score on the self-report on the PTSD symptom
scale in the group of patients who did not participate (t(118) =
2.20, P = 0.03). The demographic characteristics at baseline are pre-
sented in Supplementary Table 1, with no demographic differences
between the treatment groups, except for living condition (situ-
ation) (with relatively more cohabitating participants in the
EMDR group and more patients living alone in the STAIR–
EMDR group). Given the RCT design we did not correct for pre-
treatment differences.26
Overall pre- to post-treatment effects
In both treatment groups, participants showed significant pre- to
post-treatment reductions (i.e. a significant effect of time) on all
variables (i.e. symptoms of PTSD, symptoms of complex PTSD
and other forms of psychopathology; Supplementary Tables 2a
and 2b). The within-group effect sizes pertaining to these differ-
ences were medium to large in both groupsfor the different variables
(d = 0.50–1.70; Table 1).27 Based on the CAPS, 68.8% of all partici-
pants across treatment conditions did not fulfil the diagnostic cri-
teria for PTSD at post-treatment. Based on the SIDES, only 3.3%
of the participants still met the criteria for complex PTSD at post-
treatment (compared with 28.9% prior to treatment).
Treatment effectiveness of phase-based versus
immediate trauma-focused treatment
None of the variables showed a significant effect of treatment con-
dition or a significant treatment × time interaction effect from pre-
to post-treatment (Supplementary Tables 2a and 2b).
For three variables, we did find a differential course of symptom
decreasebetweenpre- andpost-treatment (i.e. although the levelswere
comparable at post-treatment; Supplementary Table 2a). This was the
case for self-report of PTSD symptoms (PSS-SR; F(2, 164.26) = 3.90,
P = 0.022), interpersonal problems (IIP; F(2, 155.17) = 4.86, P = 0.009)
and post-traumatic cognitions (PTCI; F(2, 158.22) = 4.17, P =
0.017). As shown in Fig. 2, a comparable pattern was present for
these three variables, as symptom decrease in the STAIR–EMDR
Phase‐based versus immediate trauma‐focused treatment for PTSD
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group only began during the EMDR part (i.e. from eight sessions to
post-treatment) and not in the STAIR part (i.e. the first eight ses-
sions). In contrast, in the EMDR group the decline in symptoms
was gradual across the sessions from pre- to post-treatment.
The dichotomous CAPS outcome did not show a significant
difference in the proportions who no longer met PTSD diagnostic
criteria between the two treatment groups at post-treatment
(66.7% in the EMDR group and 68.9% in the STAIR–EMDR
group; χ2(2, 96) = 0.05, P = 0.816). The proportion of participants
who no longer met complex PTSD diagnostic criteria was 28.8% in
the EMDR group and 22.2% in the STAIR–EMDR (pre-treat-
ment, 32.8% met the complex PTSD diagnosis in the EMDR group
and 24.6% in the STAIR–EMDR group). No significant differences
between the proportion of individuals with a reliable change on the
CAPS were found (RCI = 21.4; 53.3% in the STAIR–EMDR group
and 45.1% in the EMDR group; χ2(1, 96) = 0.36, P = 0.55).





11 not for right trauma
4 no PTSD
1 too high suicidality
151 assessed for eligibility by LEC,
CAPS, BDI.
When suitable for participation assessed
with: PSS-SR, SIDES, IIP, DERS, PTCI,
DES, BSI
PSS-SSR, IIP, DERS, PTCI PSS-SSR, IIP, DERS, PTCI
Two times 8 sessions EMDR
Post-treatment: CAPS. PSS-SR,
SIDES, IIP, DERS, PTCI, DES, BSI
Post-treatment: CAPS. PSS-SR,
SIDES, IIP, DERS, PTCI, DES, BSI
Follow-up after 3 months: CAPS,
SIDES, BSI, DES
Follow-up after 3 months: CAPS,
SIDES, BSI, DES





1 delayed exclusion due to one abuse
situation, not repeated
10 discontinued after randomisation,




2 delayed exclusion due to not meeting
the PTSD criteria
1 discontinued after randomisation, before
start of treatment
Follow-up after 6 months: CAPS,
SIDES, BSI, DES
Fig. 1 Flow of study participants.
LEC, Life Events Checklist for DSM-5 (LEC-5); CAPS, Clinician-Administered PTSD scale for DSM-5; BDI, Beck Depression Inventory (BDI-II); PSS-SR, PTSD Symptom Scale – Self-Report
version; SIDES, Structured Interview for Disorders of Extreme Stress; IIP, Inventory of Interpersonal Problems; DERS, Difficulties in Emotion Regulation Scale; PTCI, Posttraumatic
Cognitions Inventory; DES, Dissociative Experiences Scale (DES-II); BSI, Brief Symptom Inventory; PTSD, post-traumatic stress disorder; STAIR, Skills Training in Affect and
Interpersonal Regulation; EMDR, eye-movement desensitisation and reprocessing.
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Long-term treatment results
For the variables measured at follow-up (Supplementary Table 2b),
no significant treatment effect, time effect or treatment × time
interaction was found between post-treatment measurement and
the 3-month follow-up. Also, no significant changes across to
time were found between 3- and 6-month follow-up for scores on
the CAPS (t(268.42) = 0.238, P = 0.812,) SIDES (t(251.12) = 0.90,
P = 0.367), DES (t(233.63) = 1.21, P = 0.226) and BSI (t(244.00) =
0.821, P = 0.413).
Early completion, serious adverse events and drop-out
The percentage of early completers (STAIR–EMDR group: 50.9%;
EMDR group: 45.3%), participants who dropped out (STAIR–
EMDR group: 22.8%; EMDR group: 17.2%) and participants who
completed all sessions (STAIR–EMDR group: 26.3%; EMDR
group: 37.5%) did not differ significantly between the two treatment
groups at post-treatment (χ2(2, 121) = 1.85, P = 0.40). We did not
find clinical or demographic characteristics related to drop-out. In
the STAIR–EMDR group one serious non-study-related (as
assessed by the medical ethics committee) adverse event was
reported, which included short hospital admission after a suicide
attempt. In the EMDR group two non-study-related adverse
events were reported (one due to increased suicidal ideation
during the follow-up and one due to increased psychotic experi-
ences following changes in medication).
Discussion
In contrast to our hypothesis, that phase-based treatment would
lead to better treatment outcomes than stand-alone trauma-
focused treatment, no differences were found between the two treat-
ment groups on any variable indexing PTSD, complex PTSD or
other forms of psychopathology. The only differences between the
groups consisted of faster recovery (i.e. within eight sessions) in
the EMDR therapy group on self-reported PTSD symptoms, inter-
personal problems and post-traumatic cognitions, but this advan-
tage did not last, as the results between groups were found to be
comparable at later time intervals. Because the drop-out rates for
both treatment groups did not differ significantly, the hypothesis
that a phase-based treatment would lead to significantly less attri-
tion than an immediate trauma-focused treatment could also not
be supported. These results suggest that a stabilisation phase is
not a necessary condition for applying a trauma-focused treatment
in a sample of individuals with PTSD due to repeated sexual and/or
physical childhood abuse. The results confirm the findings of other
studies indicating that both phase-based and immediate trauma-
focused therapies are safe and effective treatments (e.g.28–30).
This was the third RCT that has been conducted so far compar-
ing a phase-based treatment with a trauma-focused treatment in
people with PTSD due to childhood abuse,6,7 but the first using
EMDR therapy. The results of this study are in line with both pre-
vious studies in that no differences were found between the treat-
ment groups at post-treatment in favour of a phase-based
treatment approach. In other words, both prolonged exposure
therapy and EMDR therapy are likely to be safe and effective treat-
ments for individuals suffering from symptoms of complex PTSD
due to childhood abuse, and a stabilisation phase does not addition-
ally improve treatment results. On the contrary, according to our
results, for some symptoms (i.e. interpersonal problems, post-trau-
matic cognitions), a phase-based treatment approach may even
delay the recovery process.
The present study also found no support for the hypothesis that
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EMDR only. To this end, the results are in line with the results of
Oprel et al,7 but in contrast to the study of Cloitre et al,6 which
showed that significantly fewer people dropped out of the STAIR/
exposure group compared with the support/exposure group.
However, a closer look at this study reveals that the higher drop-
out rate in the support/exposure group was largest during the sup-
portive counselling phase, not during the trauma-focused part.
Strengths and limitations
The present study has several strengths. Most important, the treat-
ments were performed in two regular psychiatric out-patient set-
tings. This increases the generalisability of these research findings.
Another strength is that therapists received individual feedback
on their treatment sessions, which may have led to treatment effi-
ciency and high levels of treatment integrity. Conversely, a limita-
tion of the study is that the two treatment groups were not
compared with an inactive control group controlling for effects
resulting from the mere passage of time. A second critical note
refers to the fact that STAIR was offered twice a week, instead of
once a week; this may have led to less time to practise new skills
in between sessions.
Future research
Despite the compelling support for the use of EMDR therapy alone
for the treatment of complex PTSD as opposed to needing any pre-
paratory intervention it remains important to investigate in future
studies whether specific symptoms of complex PTSD, and maybe
also other relevant patient characteristics, might moderate treatment
outcome in that some patients might benefit more from an immedi-
ately trauma-focused treatment whereas others may benefit more
using a phase-based approach. More specifically, because not
everyone fully benefited from EMDR therapy alone (25% still fulfilled
the diagnostic criteria for PTSD), in future research it seems sensible
and important to explore which variables determine an adequate or
less adequate treatment response, and whether there may still be
patients who benefit from some form of emotion regulation or
other skills training. In addition, future studies should investigate
the long-term effects of different trauma treatments, as the course
of separate symptoms during follow-up over the long term may
differ between the different treatments.
Clinical and management implications
Our findings, and those of other recent studies on the treatment of
symptoms of complex PTSD in relation to the phase-based
approach, fit into a new vision that is emerging on this topic; that
is, that a phase-based treatment for symptoms of complex PTSD
is effective, but not necessary. As the duration of therapy is much
longer and needs more resources in the phase-based condition,
this suggests that time and finances for commitment to treatment
of patients as well as training and supervision of therapists may
be better spent by focusing on single trauma-focused interventions.
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Self-report PTSD symptoms over time in both
treatment conditions (PSS-SR) 
Interpersonal problems over time in both
treatment conditions (IIP)


















































Fig. 2 Mean scores pre-treatment and after 8, 16 and 24 sessions for the PTSD Severity Scale Self-Report (PSS-SR), the Inventory of
Interpersonal Problems (IIP) and the Posttraumatic Cognitions Inventory (PTCI).
PTSD, post-traumatic stress disorder; STAIR, Skills Training in Affect and Interpersonal Regulation; EMDR, eye-movement desensitisation and reprocessing.
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Supplementary material
Supplementary material is available online at https://doi.org/10.1192/bjo.2021.1057.
Data availability
The data that support the findings of this study are available on request from the corresponding
author.
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